From: Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study
 | Cases/Total | Risk ratio* | 95% Confidence interval |
---|---|---|---|
Cryptorchidism | Â | Â | Â |
   Timing of DES exposure |  |  |  |
Began after 11th wk | 8/451 | 1.1 | 0.5-2.5 |
Began before 11th wk | 29/625 | 2.9 | 1.6-5.2 |
   Cumulative dose < 5 g | 7/231 | 1.9 | 0.8-4.5 |
   Cumulative dose ≥ 5 g | 20/389 | 3.2 | 1.7-6.0 |
Epididymal cyst | Â | Â | Â |
   Timing of DES exposure |  |  |  |
Began after 11th wk | 17/451 | 2.0 | 1.0-3.8 |
Began before 11th wk | 38/625 | 3.5 | 2.0-6.0 |
   Cumulative dose < 5 g | 11/231 | 2.7 | 1.3-5.7 |
   Cumulative dose ≥ 5 g | 28/389 | 4.0 | 2.3-7.1 |
Inflammation of testes | Â | Â | Â |
   Timing of DES exposure |  |  |  |
Began after 11th wk | 16/451 | 2.1 | 1.1-4.2 |
Began before 11th wk | 30/625 | 3.0 | 1.7-5.4 |
   Cumulative dose < 5 g | 9/231 | 2.0 | 1.1-3.8 |
   Cumulative dose ≥ 5 g | 23/389 | 3.2 | 1.7-5.8 |